Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Nxera Pharma Co Ltd (4565)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1,460.0 -37.0    -2.47%
26/04 - Closed. Currency in JPY ( Disclaimer )
Type:  Equity
Market:  Japan
ISIN:  JP3431300007 
  • Volume: 1,008,600
  • Bid/Ask: 1,493.0 / 1,494.0
  • Day's Range: 1,453.0 - 1,505.0
Nxera Pharma 1,460.0 -37.0 -2.47%

4565 Balance Sheet

 
Featured here, the Balance Sheet for Nxera Pharma Co Ltd, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Current Assets 65112 58305 71121 68822
Cash and Short Term Investments 49381 42715 65912 66352
Cash - - - -
Cash & Equivalents 49065 42386 65598 66138
Short Term Investments 316 329 314 214
Total Receivables, Net 11887 6220 4468 1591
Accounts Receivables - Trade, Net 5064 3888 2639 1293
Total Inventory 2903 3996 - -
Prepaid Expenses 790 - - -
Other Current Assets, Total 151 5374 741 879
Total Assets 157198 149439 104063 98719
Property/Plant/Equipment, Total - Net 7900 8092 4491 3819
Property/Plant/Equipment, Total - Gross - - - -
Accumulated Depreciation, Total - - - -
Goodwill, Net 24623 24888 16795 15660
Intangibles, Net 52291 53070 9423 8684
Long Term Investments 3308 3139 2233 1734
Note Receivable - Long Term 6823 2332 1829 298
Other Long Term Assets, Total 42 68 - -
Other Assets, Total -4553 5424 -3413 -498
Total Current Liabilities 17185 17573 4633 3371
Accounts Payable 4244 3846 1696 1286
Payable/Accrued - - - -
Accrued Expenses - - - -
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases 6773 6609 174 168
Other Current liabilities, Total 6168 7118 2763 1917
Total Liabilities 90388 91485 41401 40505
Total Long Term Debt 67200 66699 30276 29711
Long Term Debt 63215 62500 28255 28117
Capital Lease Obligations 3985 4199 2021 1594
Deferred Income Tax 1490 2033 1599 2554
Minority Interest - - - -
Other Liabilities, Total -33949 -34725 4893 4869
Total Equity 66810 57954 62662 58214
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 46807 41780 41780 41335
Additional Paid-In Capital 34048 29677 29437 29660
Retained Earnings (Accumulated Deficit) -16104 -15896 -10971 -10313
Treasury Stock - Common -1 -1 -1 -1
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 2060 2394 2417 -2467
Total Liabilities & Shareholders' Equity 157198 149439 104063 98719
Total Common Shares Outstanding 89.45 82.34 82.34 81.92
Total Preferred Shares Outstanding - - - -
* In Millions of JPY (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

4565 Comments

Write your thoughts about Nxera Pharma Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email